Abstract. To design a potent agent for positron emission tomography/magnetic resonance imaging (PET/MRI) imaging and targeted magnetic hyperthermia-radioisotope cancer therapy radiolabeled surface modifi ed superparamagnetic iron oxide nanoparticles (SPIONs) were used as nanocarriers. Folic acid was conjugated for increasing selective cellular binding and internalization through receptor-mediated endocytosis. SPIONs were synthesized by the thermal decomposition of tris (acetylacetonato) iron (III) to achieve narrow and uniform nanoparticles. To increase the biocompatibility of SPIONs, they were coated with (3-aminopropyl) triethoxysilane (APTES), and then conjugated with synthesized folic acid-polyethylene glycol (FA-PEG) through amine group of (3-aminopropyl) triethoxysilane. Finally, the particles were labeled with 64 Cu (t 1/2 = 12.7 h) using 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid mono (N-hydroxy succinimide ester) DOTA-NHS chelator. After the characterization of SPIONs, their cellular internalization was evaluated in folate receptor (FR) overexpressing KB (established from a HeLa cell contamination) and mouse fi broblast cell (MFB) lines. Eventually, active and passive targeting effects of complex were assessed in KB tumor-bearing Balb/C mice through biodistribution studies. Synthesized bare SPIONs had low toxicity effect on healthy cells, but surface modifi cation increased their biocompatibility. Moreover, KB cells viability was reduced when using folate conjugated SPIONs due to FR-mediated endocytosis, while having little effect on healthy cells (MFB). Moreover, this radiotracer had tolerable in vivo characteristics and tumor uptake. In the receptor blocked case, tumor uptake was decreased, indicating FR-specifi c uptake in tumor tissue while enhanced permeability and retention effect was major mechanism for tumor uptake.
Introduction
Nanotechnology is a new emerging science and in medicine it focuses on tumor targeting, drug delivery, controlled release, and multimodal imaging for cancer diagnosis and treatment (theranostics). There is renewed interest in using superparamagnetic iron oxide nanoparticles (SPIONs) as multifunctional platforms for in vitro cell purifi cations, cellular and molecular imaging, early tumor diagnosis and treatments [1] . Therapeutic approaches that exploit nanoparticles to deliver drugs selectively to cancer cells are currently considered one of the most promising tools in cancer therapeutics. SPIONs with appropriate surface as multifunctional carriers have been widely used for various biomedical applications owing to their biocompatibility, conjugation with targeting ligands and excellent tumor targeting. Particles with longer circulation times, and hence greater ability to target to the site of interest, should be 100 nm or less in diameter and have a hydrophilic Synthesis and evaluation of radiolabeled, folic acid-PEG conjugated, amino silane coated magnetic nanoparticles in tumor bearing Balb/C mice surface in order to reduce clearance by macrophages [2] . Nanoparticles will usually be taken up by the liver, spleen, and other parts of the reticuloendothelial system (RES) depending on their surface characteristics. Particles with more hydrophobic surfaces will preferentially be taken up by the liver, followed by the spleen and lungs. A biocompatible coating on particle surface is important for SPIONs circulation time and the stabilization of colloidal suspension. Therefore, SPIONs surface treatment with (3-aminopropyl) triethoxysilane (APTES) increases the presentation time of SPIONs in blood circulation. In addition, long-circulating nanocarriers such as polyethylene glycol (PEG) modifi ed SPIONs can preferentially accumulate in the tumor sites through the leaky tumor vasculature by the enhanced permeability and retention (EPR) effect, known as passive targeting [3] [4] [5] . The PEG coating could enhance the compatibility between nanoparticles and aqueous medium, prevent particle surface from oxidation, reduce toxicity, and facilitate storage or transport [6] . Active targeting methods using SPIONs generally involve attaching a targeting ligand to the surface of the SPIONs' polymer coating. Folate receptors (FRs) on the cell membrane are a potential molecular target for tumor targeting because the FR is highly expressed in a number of epithelial carcinomas and the FRs provide highly selective sites that differentiate tumor cells from normal cells [7] [8] [9] . FRs are also overexpressed on activated and nonresting macrophages, although functional FRs are not expressed on resting macrophages or normal epithelial cells, which helps in targeting genetically altered cells [7] . Magnetic nanoparticles have been used extensively to investigate a wide range of biological phenomena such as tumor detection [10] [11] [12] [13] [14] [15] [16] . Copper-64 (t 1/2 = 12.7 h) is a unique isotope for radioisotope therapy which decays by -(39%), +/EC (61%). Well--established coordination chemistry, as well as an attractive half-life, makes this radionuclide feasible for effi cient labeling with a wide variety of biomolecules such as peptides, antibodies, or nanoparticles. Copper-64 is commonly used in positron emission tomography (PET) imaging [17] because it can be produced at a high specifi c activity in biomedical cyclotrons [18, 19] and the chelation of 64 Cu to various macrocyclic chelators can provide an effi cient route for radiolabeling a wide variety of macromolecules and nanoparticles [20] .
Experimental

Materials
Iron(III)acetylacetonate, benzyl ether (99%), oleylamine (>70%), (3-aminopropyl) triethoxysilane (APTES), 1-ethyl-3-(-3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), dimethyl sulfoxide (DMSO), N-hydroxy succinimide (NHS), dicyclohexyl carbodiimide (DCC), pyridine and bifunctional PEG, and other chemical reagents were purchased from Sigma-Aldrich Chemicals. 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid mono (N-hydroxy succinimide ester) (DOTA--NHS) was purchased from Macrocyclics Inc. Copper-64 was produced on AMIRS Cyclon 30, IBA cyclotron.
Synthesis and surface modifi cation of SPIONs
SPIONs were synthesized through thermal decomposition method [21] [22] [23] [24] . Briefl y, 1.4 g of tris (acetylacetonato) iron (III) [Fe (acac) 3 ] was dissolved in a mixture of benzyl ether and oleylamine (20 ml/ 20 ml). The solution was dehydrated at 120°C for 1 h and quickly heated to 290°C for 2 h. After cooling, 65 mL of ethanol was added to the mixture. The precipitate was collected by centrifugation at 5000 rpm followed by washing in ethanol thrice. Final product was redispersed in hexane and stored at 4°C. Amino groups in the SPIONs were introduced by the reaction of the SPIONs with APTES via the replacement of alkoxide groups by hydroxyl groups to form reactive silanol group [7] .
Synthesis of FA-PEG and FA-PEG-SPIONs
Folic acid was conjugate to PEG using DCC/NHS as activation agents. Briefl y, 100 mg folic acid was activated in DMSO by 100 mg DCC and 55 mg NHS for 12 h at room temperature. Activated folic acid was coupled to amine groups of NH 2 -PEG--COOH using pyridine at room temperature for 6 h followed by dialysis using Spectra/Por (molecular weight cut-off 1 kDa) and followed by lyophilization [7] . Synthesized FA-PEG (230 mg) was conjugated to amine-terminated of APTES-coated SPIONs (46 mg) using EDC/NHS at room temperature for 12 h followed by dialysis against water at 4°C for 48 h and lyophilization.
Radiolabeling of modifi ed SPIONs with copper-64
DOTA-NHS-ester (3.5 mg) in 1 mL of PBS (pH 7.5, 1 mM) was reacted with 3.75 mL of FA-PEG--SPIONs (65 mg) overnight at 4°C. DOTA-SPIONs were separated from excess DOTA-NHS-ester by dialysis for 48 h at 4°C using 2 L of PBS. Synthesized DOTA-SPIONs (8 mg in 600 l) were incubated with 64 CuCl 2 (74 MBq) in 0.1 M ammonium acetate buffer (pH 5.5) at 35°C for 90 min in a thermomixer. The solution was mixed with 10 l of EDTA (10 mM) and was incubated for another 10 min. It was passed through PD10 columns (Amersham) to remove excess unbound 64 Cu. Radiolabeling yield was determined by thin layer chromatography (TLC). Briefl y, small amount of 64 Cu labeled SPIONs was applied to an SG plate and developed using a 1:1 mixture (v/v) of 10% (w/v) ammonium acetate and methanol. The radioactivity in the TLC plate was measured using a Bioscan scanner (Bioscan Inc.). The nanoparticle solution was then diluted with PBS to obtain suitable doses for biodistribution studies. Synthesis steps are demonstrated in Fig. 1 .
In vitro cytotoxicity studies
Mouse fi broblasts (MFCs) and folate receptor (FR) overexpressing KB cell lines were seeded in 96-well plates at 10 4 cells/well and incubated for 24 h. The cells were grown and maintained in DMEM (Dulbecco's Modifi ed Eagle's Medium) supplemented with 10% fetal bovine serum (FBS) incubated in a humidifi ed atmosphere (95% air and 5% CO 2 ) at 37°C. After a 24 h incubation period, medium containing control cells, bare SPIONs, and modifi ed SPIONs (0.2 mM iron) was added to the wells and cells were incubated at 37°C for 1 h. The medium was then extracted, and the cells were allowed to rest. At 24 h post-treatment, the cell viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide MTT assay and using an ELISA reader (microreader, Hyperion) at 545 nm.
Biodistribution studies
In order to carry out biodistribution studies of complex, 64 Cu-labeled SPIONs (3.7 MBq, 0.4 mg Fe) in 100 L of PBS were injected intravenously via the tail vein into KB tumor-bearing Balb/C mice (20-25 g, 6-8 weeks old, 0.5 cm tumor volume, n = 5). The mice were sacrifi ced at 4, 24, 48, and 72 h after injection. Animal organs were removed and weighed, and the amount of incorporated 64 Cu was measured by the determination of area under the curve of 511 keV peaks using a HPGe gamma detector (Canberra). FRs blockade experiments were performed at 4 and 24 h after injection, with mice injected with excess folic acid (150 g). The activities present in the harvested organs (blood, liver, spleen, kidney, stomach, intestine, muscle, heart, lung, and tumor) were compared with the percentage of injected activity per gram of organ (% ID·g −1 ). All animal experiments were performed in compliance with the regulations of our institution for animal experiments.
Results
Nanoparticles characterization
APTES-coated SPIONs used in this experiment were monodisperse ( Fig. 2A) having an average diameter of 14 nm as determined by transmission electron microscope -TEM (Zeiss). Moreover, it was found that DOTA-SPIONs could be labeled with a yield of 96 ± 1.3%. Figure 2B shows the TLC pattern of 64 Cu-labeled modifi ed SPIONs. The stability of 64 Cu-SPIONs was determined by incubating labeled nanoparticles in PBS and mouse serum at 4°C and 37°C, respectively, with constant shaking up to 24 h. The samples were subjected to frequent TLC analysis to measure the amount of activity dissociated from 64 Cu-SPIONs. In vitro stability of complex in PBS and serum was 93.6 ± 1.2% and 85.3 ± 2.6%, respectively. In addition, the sizes of modifi ed SPIONs were little increased up to 4 weeks at 4°C (data not shown), confi rming stable particles size and dispersion.
In vitro and in vivo assays
Influence of bare and APTES-treated, PEG-FA conjugated SPIONs on fi broblast cell viability at 24 h post-treatment is shown in Fig. 3 . Synthesized bare SPIONs have low toxicity effects (cell viability was reduced to 86.7% in healthy cells) as shown in Fig. 3 (no. 2, red) , but surface modifi cation with appropriate coating (APTES and PEG) prevented cytotoxic effect. Modifi ed SPIONs are more biocompatible than bare SPIONs (cell viability was reduced to 96.7% in healthy cells) as shown in Fig. 3 (no. 3, green) . Moreover, KB cells viability was reduced when using folate-conjugated SPIONs due to FR-mediated endocytosis, while having little effect on healthy mouse fi broblast cell (MFB). Moreover, the biodistribution of 64 Cu-labeled, APTES-coated, PEG-FA conjugated SPIONs in tumor bearing Balb/C mice were studied. Radiolabeled nanoparticles were injected to tail vein and then, accumulation in major organs was investigated. The results of biodistribution and tumor/organs uptake ratios in folate targeting are given in Fig. 4 (A and B) , whereas the results of blockade studies are given Fig. 4C and D.
Discussion
The FRs are emerging as a promising tumor-associated targets. The FR-specifi c accumulation of radiolabeled surface modifi ed nanoparticles in normal and tumor organs was evaluated. This radiotracer allowed highly specifi c radiolabeling and tolerable in vivo characteristics with good tumor uptake. High retention of radioactivity in kidneys is a critical issue of FR targeting strategy in general. Because FRs are expressed on the luminal side of brush border membrane, they are exposed to the high folate conjugate concentration in the primary urine [25] . As a consequence, folate is signifi cantly and specifi cally accumulated in the renal tissues. High binding and uptake of radioactivity into the renal tissue is a logical consequence of FR expression in proximal tubule cells, which is particularly undesirable regarding the development of therapeutic radiofolates [25] .
When receptors were blocked, tumor uptake at 4 and 24 h postinjection decreased from 3.98 ± 0.24% and 5.42 ± 0.44% ID/g to 2.02 ± 0.48% and 1.86 ± 0.58% ID/g, respectively, indicating FR-specifi c uptake in tumor tissue. In addition, tumor/muscle ratio was reduced to half in comparison with FR targeting at 24 h postinjection. In the absence of folate targeting, EPR effect of nanoparticles is the major mechanism of uptake. Radioactivity accumulation in tumor was high at 48 and 72 h after injection (5.1 ± 0.47% and 3.1 ± 0.48% ID/g). Maximal tumor Cu-labeled folate-conjugated shell cross-linked nanoparticles experiment [26] is shown in Table 1 . In comparison with [19] experiment ( 64 Cu labeled magnetic nanoparticles), blood uptake increased from 1.1 ± 0.05% to 1.8% ID/g. While liver and kidney uptakes were decreased from 31.33 ± 2.33% and 6.20 ± 0.38% to 5.29 ± 0.49% ID/g and 4.8 ± 0.58% ID/g at 24 h after injection due to appropriate nanoparticles surface modifi cations. These modifi cations lead to escape of SPIONs from RES. Comparing to our previous 64 Cu-labeled, antibody conjugated magnetic nanoparticles experiment [27] , tumor uptake and tumor/liver, tumor/ kidney, tumor/blood ratios decreased from 12.5 ± 1.2%, 1.32 ± 0.10%, 1.83 ± 0.14%, 4.63 ± 0.64% to 5.29 ± 0.49%, 1.03 ± 0.08%, 1.15 ± 0.18%, 3.08 ± 0.67% at 24 h postinjection. Although tumor/organs ratios and tumor uptakes are smaller than antibody--conjugated SPIONs, folic acid-coated SPIONs are less expensive and can be prepared with relative ease.
Conclusion
Nanoparticles are well suited to design bioprobes, because of their relatively large surface area which permits high specific activity labeling and also increases payload of targeting ligands. Folic acid was conjugated on the surface of nanoparticles through PEG attachment for the effective targeting of FR-positive tumor cells. The results of MTT assay showed the infl uence of APTES-treated, PEG--FA-conjugated SPIONs on cancer cell death while they had small cytotoxic effect on healthy cells. The selective tumor localization of PEG-FA-treated nanoparticles should be mostly attributable to their long residence in blood circulation, leakage of blood vessels in tumors, and FR endocytosis. Therefore, our biocompatible 64 Cu-labeled, APTES-coated, PEG-FA-conjugated SPIONs could serve as nanoplatforms in tumor targeting. with Presidential Fund for Researchers and Technologists under no. 91053278. This research has been partially supported by Iran National Science Foundation, Science Deputy of Presidency under the research project no. 91053278. 
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